Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study
- PMID: 21853543
- PMCID: PMC3160695
- DOI: 10.3325/cmj.2011.52.488
Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study
Abstract
Aim: To determine the prevalence, number, and location of multiple (≥2) T2-hyperintensities on brain magnetic resonance imaging (MRI) in children with neurofibromatosis type 1 (NF1) and their correlation with age, and to establish their sensitivity, specificity, and accuracy for the diagnosis of NF1 in children, especially in the early age (2-7 years).
Methods: We performed a cross-sectional study of 162 patients with NF1 from Croatian Neurofibromatosis Association Database and 163 control children between the ages of 2 and 18 years who underwent brain MRI between 1989 and 2009.
Results: Multiple T2-hyperintensities were present in 74% of NF1 patients and 1.8% of controls. They were mainly located in the basal ganglia, brainstem, and cerebellum and were significantly decreased in prevalence and number in the older age. T2-hyperintensities had excellent diagnostic accuracy with the area under the receiver operating characteristic (ROC) curve of 0.849 and 95% confidence interval (CI) of 0.805-0.886. The diagnostic sensitivity, specificity, and accuracy rate of T2-hyperintensities for NF1 were highest in the youngest age (2-7 years): 81% (95% CI 71%-89.1%), 99% (95% CI 92.3%-100%), and 85.8 (95% CI 83.3-93.8), respectively.
Conclusion: This study strongly suggests the inclusion of T2-hyperintensities on brain MRI on the list of diagnostic criteria for NF1, especially in children of early age, when the clinical penetration of the NF1 gene has not yet been completely finished.
Figures





Similar articles
-
Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?Pediatr Neurol. 2015 Mar;52(3):314-9. doi: 10.1016/j.pediatrneurol.2014.11.014. Epub 2014 Dec 1. Pediatr Neurol. 2015. PMID: 25585912
-
Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.Neurology. 2003 Apr 8;60(7):1139-45. doi: 10.1212/01.wnl.0000055090.78351.c1. Neurology. 2003. PMID: 12682321
-
Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain?Pediatr Neurol. 2018 Sep;86:63-65. doi: 10.1016/j.pediatrneurol.2018.07.005. Epub 2018 Jul 20. Pediatr Neurol. 2018. PMID: 30174245
-
Cerebrovascular dysplasia in neurofibromatosis type 1.J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1165-70. doi: 10.1136/jnnp.2007.136457. Epub 2008 May 9. J Neurol Neurosurg Psychiatry. 2008. PMID: 18469031 Review.
-
Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.Anticancer Res. 2016 Aug;36(8):4095-121. Anticancer Res. 2016. PMID: 27466519 Review.
Cited by
-
Epilepsy in NF1: Epidemiologic, Genetic, and Clinical Features. A Monocentric Retrospective Study in a Cohort of 784 Patients.Cancers (Basel). 2021 Dec 17;13(24):6336. doi: 10.3390/cancers13246336. Cancers (Basel). 2021. PMID: 34944956 Free PMC article.
-
Neuroimaging Reader Study on Clinical Sensitivity and Specificity Using Synthetic MRI Based on MR Quantification.AJNR Am J Neuroradiol. 2025 Jun 3;46(6):1196-1202. doi: 10.3174/ajnr.A8631. AJNR Am J Neuroradiol. 2025. PMID: 40404350
-
Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1.Neurol Clin Pract. 2018 Aug;8(4):283-291. doi: 10.1212/CPJ.0000000000000494. Neurol Clin Pract. 2018. PMID: 30140579 Free PMC article.
-
Synthetic MRI for Clinical Neuroimaging: Results of the Magnetic Resonance Image Compilation (MAGiC) Prospective, Multicenter, Multireader Trial.AJNR Am J Neuroradiol. 2017 Jun;38(6):1103-1110. doi: 10.3174/ajnr.A5227. Epub 2017 Apr 27. AJNR Am J Neuroradiol. 2017. PMID: 28450439 Free PMC article.
-
Chinese patient with neurofibromatosis-Noonan syndrome caused by novel heterozygous NF1 exons 1-58 deletion: a case report.BMC Pediatr. 2020 May 1;20(1):190. doi: 10.1186/s12887-020-02102-z. BMC Pediatr. 2020. PMID: 32357851 Free PMC article.
References
-
- Crowe FW, Schull WJ, Neel JV. A clinical, pathological, and genetic study of multiple neurofibromatosis. Springfield, (IL): Charles C. Thomas; 1956.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous